Evidence mapPaperPMID 41302325Full record

ArticleHealthcare (Basel, Switzerland)2025

CVD Mortality Disparities with Risk Factor Associations Across U.S. Counties.

David H An

Abstract read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

David H AnHarvard University, Massachusetts Hall, Cambridge, MA 02138, USA.ORCID 0009-0007-8709-7739

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCardiovascular disease (CVD) remains a primary cause of mortality worldwide, with persistent geographic disparities driven by a complex interplay of risk factors. Continual updates of localized variations in CVD mortality are essential to develop targeted interventions for optimizing disease and healthcare management.

methodsThis study investigated associations between CVD mortality and a comprehensive set of biological, environmental, behavioral, and socioeconomic factors across all U.S. counties, employing correlation, geospatial visualization, stepwise multiple regression, and machine learning models to evaluate the importance of risk associations.

resultsSignificant disparities in CVD mortality trend were observed across race, age, sex, and region, with elevated rates among older adults, men, and Blacks, particularly in southeastern states exhibiting severe social vulnerability. Correlation analysis identified disease management (e.g., COPD, hypertension, medication non-adherence), environmental factors (PM2.5), lifestyle behaviors (e.g., smoking, sleep duration), and socioeconomic status (e.g., poverty, single-parent households, education) as important contributors to CVD mortality. Conversely, higher household income, physical activity, and cardiac rehabilitation participation were strong protectors. Multiple regression explained 66.9% variance in CVD mortality, recognizing PM2.5, smoking, and medication non-adherence as top associated factors. Random Forest models underscored COPD's predictive dominance, followed by medication non-adherence, smoking, and sleep duration.

conclusionsThe findings highlight the geospatial connection of risk factors to CVD mortality disparities across U.S. counties. They emphasize the critical importance of data-driven strategies targeting air quality, tobacco control, social inequities, and chronic disease management to mitigate CVD burden and promote health equity.

Indexed as

cardiovascular diseasecorrelationgeospatial distributionrisk factorsstatistical modeling

Identifiers

PMID41302325
PMCPMC12652022

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.